Eli Lillys recent approval for Zepbound, a GLP-1/GIP receptor agonist known as Mounjaro in the diabetes market, sets the stage for a fierce battle with Novo for market dominance
What is GHK-Cu and why 50mg vials are common GHK-Cu is the most researched anti-aging peptide
VAT The first selective growth hormone secretagogue that stimulates GH release without affecting ACTH, cortisol, or prolactin levels, investigated for bone health, muscle preservation, and gastrointestinal recovery
it can also reduce your risk of serious conditions such as heart disease, type 2 diabetes, and joint problems
The medication has undergone extensive clinical evaluation through the SUSTAIN trials for diabetes and STEP trials for weight management, establishing both efficacy and safety across diverse patient populations